Rebaz M. Ali (2023) “Pembrolizumab (Anti-PD-1) Immunotherapy in Malignant Pleural Mesothelioma: A Systematic Review of the Current Literature”, Barw Medical Journal [Preprint]. doi:10.58742/bmj.v1i2.34.